Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action lawsuit against Vocera Communications, Inc. (“Vocera” or the “Company”) (NASDAQ: VCRA) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 13-cv-03872, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired securities of Vocera between March 28, 2012 and May 3, 2013 both dates inclusive (the “Class Period”). This class action seeks to recover damages against the Company and certain of its officers and directors as a result of alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, as well as Sections 11, 12(a)(2) and 15 of the Securities Act of 1933.
If you are a shareholder who purchased Vocera securities during the Class Period, you have until September 30, 2013 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at
. To discuss this action, contact Robert S. Willoughby at
or 888.476.6529 (or 888.4-POMLAW), toll free, x237. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.
Vocera is a leading provider of mobile communication solutions to healthcare and non-healthcare markets. The Company is headquartered in San Jose, California. Vocera offers software applications, hands-free wearable voice-controlled communication badges, smartphones, and other wireless devices to hospitals and to other enterprises where workers are highly mobile.
The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, during the Class Period, the Company made false and/or misleading statements and/or failed to disclose: (i) the extent of the adverse impact that healthcare reform was having on sales of the Company’s communication products to hospitals; and (ii) the extent of the adverse impact that the federal budget sequestration was having on sales of the Company’s communication products to government hospitals.